Analysts Expect Tenet Healthcare Corp (THC) Will Post Quarterly Sales of $4.55 Billion

Brokerages forecast that Tenet Healthcare Corp (NYSE:THC) will announce $4.55 billion in sales for the current quarter, according to Zacks. Eight analysts have issued estimates for Tenet Healthcare’s earnings. The lowest sales estimate is $4.46 billion and the highest is $4.61 billion. Tenet Healthcare posted sales of $4.80 billion during the same quarter last year, which suggests a negative year-over-year growth rate of 5.2%. The company is scheduled to report its next quarterly earnings report on Monday, August 6th.

On average, analysts expect that Tenet Healthcare will report full year sales of $18.14 billion for the current year, with estimates ranging from $18.08 billion to $18.21 billion. For the next year, analysts forecast that the business will report sales of $18.08 billion per share, with estimates ranging from $16.86 billion to $18.89 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that follow Tenet Healthcare.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Monday, April 30th. The company reported $0.57 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.04) by $0.61. Tenet Healthcare had a positive return on equity of 23.13% and a negative net margin of 2.90%. The firm had revenue of $4.70 billion for the quarter, compared to analyst estimates of $4.56 billion. During the same period last year, the company earned ($0.27) earnings per share. The firm’s revenue for the quarter was down 2.4% on a year-over-year basis.

THC has been the topic of several analyst reports. Zacks Investment Research raised Tenet Healthcare from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a research report on Monday, May 28th. Mizuho reissued a “buy” rating and set a $29.00 price target on shares of Tenet Healthcare in a report on Thursday, March 22nd. Citigroup raised their price target on Tenet Healthcare from $19.00 to $27.00 and gave the company a “buy” rating in a report on Thursday, March 1st. JPMorgan Chase & Co. raised their price target on Tenet Healthcare from $15.00 to $18.00 and gave the company an “underweight” rating in a report on Monday, March 5th. Finally, Wells Fargo & Co raised their price target on Tenet Healthcare from $20.00 to $22.00 and gave the company a “market perform” rating in a report on Wednesday, February 28th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have given a buy rating to the company’s stock. Tenet Healthcare currently has a consensus rating of “Hold” and a consensus price target of $26.69.

A number of hedge funds have recently made changes to their positions in the stock. Geode Capital Management LLC boosted its stake in Tenet Healthcare by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 659,123 shares of the company’s stock valued at $9,992,000 after buying an additional 3,302 shares in the last quarter. Allianz Asset Management GmbH boosted its stake in Tenet Healthcare by 2.7% during the first quarter. Allianz Asset Management GmbH now owns 150,325 shares of the company’s stock valued at $3,645,000 after buying an additional 3,950 shares in the last quarter. Cubist Systematic Strategies LLC boosted its stake in Tenet Healthcare by 286.0% during the first quarter. Cubist Systematic Strategies LLC now owns 7,700 shares of the company’s stock valued at $187,000 after buying an additional 5,705 shares in the last quarter. Northwestern Mutual Investment Management Company LLC boosted its stake in Tenet Healthcare by 56.5% during the first quarter. Northwestern Mutual Investment Management Company LLC now owns 16,551 shares of the company’s stock valued at $401,000 after buying an additional 5,976 shares in the last quarter. Finally, Xact Kapitalforvaltning AB boosted its stake in Tenet Healthcare by 63.3% during the first quarter. Xact Kapitalforvaltning AB now owns 16,518 shares of the company’s stock valued at $401,000 after buying an additional 6,400 shares in the last quarter.

Shares of Tenet Healthcare opened at $36.25 on Tuesday, according to MarketBeat.com. Tenet Healthcare has a 1-year low of $12.25 and a 1-year high of $38.81. The company has a current ratio of 1.24, a quick ratio of 1.17 and a debt-to-equity ratio of 23.09. The firm has a market capitalization of $3.74 billion, a price-to-earnings ratio of 44.75, a P/E/G ratio of 1.83 and a beta of 0.93.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Get a free copy of the Zacks research report on Tenet Healthcare (THC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply